Compound Microscope:
A compound microscope consists of two lenses: the objective lens and the eyepiece. The objective lens forms a real, inverted, and magnified image of the object, and the eyepiece magnifies this image further.

- The object is placed slightly inside the focal point of the objective lens.
- The objective lens produces a real, inverted, and magnified image, which acts as the object for the eyepiece.
- The eyepiece forms an image at infinity, as the final image is formed at infinity (in a relaxed eye condition).
The total magnification \( M_{\text{total}} \) of the microscope is the product of the magnification produced by the objective lens \( M_{\text{obj}} \) and the magnification produced by the eyepiece \( M_{\text{eyepiece}} \):
\[ M_{\text{total}} = M_{\text{obj}} \times M_{\text{eyepiece}} \]
The magnification of the objective lens is given by:
\[ M_{\text{obj}} = - \frac{v_{\text{obj}}}{u_{\text{obj}}} \]
Where \( v_{\text{obj}} \) is the image distance and \( u_{\text{obj}} \) is the object distance for the objective lens.
The magnification of the eyepiece is given by:
\[ M_{\text{eyepiece}} = \frac{D}{f_{\text{eyepiece}}} \]
Where \( D \) is the near point distance of the eye (usually taken as 25 cm), and \( f_{\text{eyepiece}} \) is the focal length of the eyepiece.
Thus, the total magnification is the product of these two magnifications.
(A) Explain the following reactions and write chemical equations involved:
(a) Wolff-Kishner reduction
(b) Etard reaction
(c) Cannizzaro reaction
Following is the extract of the Balance Sheet of Vikalp Ltd. as per Schedule-III, Part-I of Companies Act as at $31^{\text {st }}$ March, 2024 along with Notes to accounts:
Vikalp Ltd.
Balance Sheet as at $31^{\text {st }}$ March, 2024
| Particulars | Note No. | $31-03-2024$ (₹) | $31-03-2023$ (₹) |
| I. Equity and Liabilities | |||
| (1) Shareholders Funds | |||
| (a) Share capital | 1 | 59,60,000 | 50,00,000 |
‘Notes to accounts’ as at $31^{\text {st }}$ March, 2023:
| Note | Particulars | $31-3-2023$ (₹) |
| No. | ||
| 1. | Share Capital : | |
| Authorised capital | ||
| 9,00,000 equity shares of ₹ 10 each | 90,00,000 | |
| Issued capital : | ||
| 5,00,000 equity shares of ₹ 10 each | 50,00,000 | |
| Subscribed capital : | ||
| Subscribed and fully paid up | ||
| 5,00,000 equity shares of ₹ 10 each | 50,00,000 | |
| Subscribed but not fully paid up | Nil | |
| 50,00,000 |
‘Notes to accounts’ as at $31^{\text {st }}$ March, 2024:
| Note | Particulars | $31-3-2024$ (₹) |
| No. | ||
| 1. | Share Capital : | |
| Authorised capital | ||
| 9,00,000 equity shares of ₹ 10 each | 90,00,000 | |
| Issued capital : | ||
| 6,00,000 equity shares of ₹ 10 each | 60,00,000 | |
| Subscribed capital : | ||
| Subscribed and fully paid up | ||
| 5,80,000 equity shares of ₹ 10 each | 58,00,000 | |
| Subscribed but not fully paid up | ||
| 20,000 equity shares of ₹ 10 each, | ||
| fully called up | 2,00,000 | |
| Less : calls in arrears | ||
| 20,000 equity shares @ ₹ 2 per share | 40,000 | |
| 59,60,000 |